We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
HighPeak Energy
HPK
$903M
| $18.2K | 0.02% |
+1,155
| New | +$17.1K |
|
1127
Dr. Reddy's Laboratories
RDY
$9.82B
| $18.2K | 0.02% |
1,240
-2,590
| -68% | -$37.8K |
|
1128
ProPetro Holding
PUMP
$1.36B
| $18.1K | 0.02% |
2,243
-1,337
| -37% | -$10.4K |
|
1129
CBRE Group
CBRE
$41.8B
| $17.9K | 0.02% |
184
-315
| -63% | -$28.3K |
|
1130
Columbia Banking Systems
COLB
$8.74B
| $17.7K | 0.02% |
+916
| New | +$18.8K |
|
1131
Sana Biotechnology
SANA
$910M
| $17.6K | 0.02% |
+1,757
| New | +$13.2K |
|
1132
Kanzhun
BZ
$6.92B
| $17.5K | 0.02% |
1,001
-550
| -35% | -$8.67K |
|
1133
PubMatic
PUBM
$599M
| $17.5K | 0.02% |
+737
| New | +$13.2K |
|
1134
Compañía de Minas Buenaventura
BVN
$7.87B
| $17.3K | 0.02% |
+1,088
| New | +$16.9K |
|
|
ETRN
1135
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $17.3K | 0.02% |
1,382
-710
| -34% | -$7.62K |
|
1136
Valaris
VAL
$5.42B
| $17.2K | 0.02% |
229
+10
| +5% | +$670 |
|
1137
Disc Medicine
IRON
$2.86B
| $17K | 0.02% |
+273
| New | +$17.7K |
|
|
SEI
1138
Solaris Energy Infrastructure
SEI
$3.27B
| $16.9K | 0.02% |
+1,955
| New | +$15.3K |
|
1139
Ericsson
ERIC
$31.4B
| $16.9K | 0.02% |
3,075
-208
| -6% | -$1.17K |
|
1140
Nice
NICE
$5.52B
| $16.9K | 0.02% |
65
-280
| -81% | -$63.5K |
|
1141
AbCellera Biologics
ABCL
$1.63B
| $16.9K | 0.02% |
+3,728
| New | +$19K |
|
|
CCRN
1142
DELISTED
Cross Country Healthcare
CCRN
| $16.7K | 0.02% |
+893
| New | +$17.9K |
|
1143
Four Corners Property Trust
FCPT
$2.87B
| $16.6K | 0.01% |
680
-576
| -46% | -$13.9K |
|
|
1144
NextDecade
NEXT
$1.78B
| $16.4K | 0.01% |
2,892
-113,134
| -98% | -$565K |
|
1145
Credo Technology Group
CRDO
$37.2B
| $16.3K | 0.01% |
767
-608
| -44% | -$12.7K |
|
1146
GeoPark
GPRK
$621M
| $16.2K | 0.01% |
1,689
+114
| +7% | +$1.01K |
|
1147
Diamondback Energy
FANG
$56.1B
| $16.1K | 0.01% |
81
-351
| -81% | -$59.6K |
|
1148
Camden Property Trust
CPT
$11.2B
| $16K | 0.01% |
+163
| New | +$15.8K |
|
1149
Constellation Brands
STZ
$22.2B
| $16K | 0.01% |
59
-20
| -25% | -$5.06K |
|
|
GDEN
1150
DELISTED
Golden Entertainment
GDEN
| $15.8K | 0.01% |
428
-214
| -33% | -$7.92K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.